SEC Form 4 · accession 0001534424-17-000184
ClearPoint Neuro, Inc. · CLPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
R John Fletcher
Director
Period of report
May 9, 2017
Accepted (ET)
May 11, 2017 · 8:33 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001285550
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $6.40 | May 9, 2017 | A | 1,125 | A | — | May 9, 2027 | Common Stock | 1,125 | 1,125 | D |
Explanation of responses
- F1The shares subject to this option vest ratably on the first, second and third anniversaries of the grant date, May 9, 2018, May 9, 2019 and May 9, 2020.